HALO Return on Tangible Equity | HALOZYME THERAPEUTICS, INC.

HALOZYME THERAPEUTICS, INC. (HALO) Return on Tangible Equity

2026-06-30: Return Tang Equity -30.40%.
2026-03-31: Return Tang Equity -26.54%.
2025-12-31: Return Tang Equity -20.94%.
2025-09-30: Return Tang Equity -279.90%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-30.40%
2026-03-31	-26.54%
2025-12-31	-20.94%
2025-09-30	-279.90%
2025-06-30	-138.74%
2025-03-31	-179.82%
2024-12-31	-109.35%
2024-09-30	-117.15%
2024-06-30	-65.36%
2024-03-31	-49.39%
2023-12-31	-37.19%
2023-09-30	-41.65%
2023-06-30	-32.10%
2023-03-31	-21.87%
2022-12-31	-27.42%
2022-09-30	-21.29%
2022-06-30	-44.50%
2022-03-31	167.11%
2021-12-31	204.47%
2021-09-30	145.24%
2021-06-30	191.01%
2021-03-31	241.26%
2020-12-31	85.46%
2020-09-30	21.74%
2020-06-30	-37.60%
2020-03-31	-138.07%
2019-12-31	-78.72%
2019-09-30	-16.29%
2019-06-30	-16.46%
2019-03-31	-19.64%
2018-12-31	-32.28%
2018-09-30	19.05%
2018-06-30	29.92%
2018-03-31	25.81%
2017-12-31	30.22%
2017-09-30	-121.98%
2017-06-30	-206.30%
2017-03-31	198.47%
2016-12-31	317.18%
2016-09-30	594.72%
2016-06-30	-673.72%
2016-03-31	-125.34%
2015-12-31	-74.96%
2015-09-30	-131.52%
2015-06-30	-74.94%
2015-03-31	-151.64%
2014-12-31	-165.35%
2014-09-30	-213.04%
2014-06-30	-152.08%
2014-03-31	-135.94%
2013-12-31	417.60%
2013-09-30	1890.19%
2013-06-30	-597.75%
2013-03-31	-182.19%
2012-12-31	-109.61%
2012-09-30	-131.98%
2012-06-30	-61.23%
2012-03-31	-31.15%
2011-12-31	-181.36%
2011-09-30	-67.45%
2011-06-30	-178.64%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-20.94%
2024-12-31	-109.35%
2023-12-31	-37.19%
2022-12-31	-27.42%
2021-12-31	204.47%
2020-12-31	85.46%
2019-12-31	-78.72%
2018-12-31	-32.28%
2017-12-31	30.22%
2016-12-31	317.18%
2015-12-31	-74.96%
2014-12-31	-165.35%
2013-12-31	417.60%
2012-12-31	-109.61%
2011-12-31	-181.36%
2010-12-31	-261.61%
2009-12-31	-845.39%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78